Literature DB >> 9588109

Type IV hypersensitivity in the pathogenesis of FIPV-induced lesions.

S Paltrinieri1, M Cammarata Parodi, G Cammarata, M Mambretti.   

Abstract

In focal lesions of feline infectious peritonitis (FIP), the cells involved in the delayed-type hypersensitivity were identified in formalin-fixed paraffin-embedded and frozen samples taken from 35 affected cats. The clinical diagnosis of FIP was confirmed by necropsy, histology and direct immunofluorescence against the coronaviruses on cryostatic sections. The immune cells were detected immunohistochemically by the Avidin-Biotin-Complex (ABC) method using either polyclonal antibodies against lymphoid antigens (CD3) or monoclonal antibodies against lymphoid (PAN-T, CD4, CD8) and myeloid antigens (MAC387). Better identification of T cells and macrophages was found on formalin-fixed paraffin-embedded sections than on cryostatic ones, while T lymphocyte subpopulations could be differentiated only in cryostatic sections. Type IV hypersensitivity was detected in focal feline infectious peritonitis virus (FIPV)-induced lesions from progressive activation of T lymphocytes, mainly CD4+, and the presence of granulocytes and macrophages. The FIPV-induced lesions could be studied as examples of granulomas caused by unconventional antigens, such as viruses or immune complexes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588109     DOI: 10.1111/j.1439-0450.1998.tb00778.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  11 in total

1.  Laboratory profiles in cats with different pathological and immunohistochemical findings due to feline infectious peritonitis (FIP).

Authors:  S Paltrinieri; V Grieco; S Comazzi; M Cammarata Parodi
Journal:  J Feline Med Surg       Date:  2001-09       Impact factor: 2.015

Review 2.  A review of feline infectious peritonitis virus infection: 1963-2008.

Authors:  Niels C Pedersen
Journal:  J Feline Med Surg       Date:  2009-02-28       Impact factor: 2.015

Review 3.  Feline coronavirus in multicat environments.

Authors:  Yvonne Drechsler; Ana Alcaraz; Frank J Bossong; Ellen W Collisson; Pedro Paulo V P Diniz
Journal:  Vet Clin North Am Small Anim Pract       Date:  2011-11       Impact factor: 2.093

4.  Cellular composition and interferon-gamma expression of the local inflammatory response in feline infectious peritonitis (FIP).

Authors:  A-L Berg; K Ekman; S Belák; M Berg
Journal:  Vet Microbiol       Date:  2005-09-23       Impact factor: 3.293

5.  Hyposialylated α1-acid glycoprotein inhibits phagocytosis of feline neutrophils.

Authors:  G Rossi; L Capitani; F Ceciliani; L Restelli; S Paltrinieri
Journal:  Res Vet Sci       Date:  2013-05-31       Impact factor: 2.534

6.  Shifts in circulating lymphocyte subsets in cats with feline infectious peritonitis (FIP): pathogenic role and diagnostic relevance.

Authors:  Saverio Paltrinieri; Wilma Ponti; Stefano Comazzi; Alessia Giordano; Giorgio Poli
Journal:  Vet Immunol Immunopathol       Date:  2003-12-15       Impact factor: 2.046

7.  Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats.

Authors:  Ádám Bálint; Attila Farsang; Levente Szeredi; Zoltán Zádori; Sándor Belák
Journal:  Vet Microbiol       Date:  2013-10-29       Impact factor: 3.293

8.  Some aspects of humoral and cellular immunity in naturally occuring feline infectious peritonitis.

Authors:  S Paltrinieri; M P Cammarata; G Cammarata; S Comazzi
Journal:  Vet Immunol Immunopathol       Date:  1998-10-23       Impact factor: 2.046

9.  Tissue distribution of a feline AGP related protein (fAGPrP) in cats with feline infectious peritonitis (FIP).

Authors:  S Paltrinieri; A Giordano; F Ceciliani; G Sironi
Journal:  J Feline Med Surg       Date:  2004-04       Impact factor: 2.015

Review 10.  Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): Are they similar?

Authors:  Saverio Paltrinieri; Alessia Giordano; Angelica Stranieri; Stefania Lauzi
Journal:  Transbound Emerg Dis       Date:  2020-10-20       Impact factor: 4.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.